Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-28,300
Closed -$773K 12874
2025
Q3
$773K Sell
28,300
-9,500
-25% -$287K ﹤0.01% 8105
2025
Q2
$1.09M Buy
37,800
+100
+0.3% +$2.84K ﹤0.01% 6898
2025
Q1
$1.08M Buy
37,700
+36,700
+3,670% +$1.39M ﹤0.01% 6783
2024
Q4
$44.8K Sell
1,000
-22,700
-96% -$1.07M ﹤0.01% 12501
2024
Q3
$1.05M Sell
23,700
-32,200
-58% -$1.32M ﹤0.01% 6777
2024
Q2
$2.16M Buy
55,900
+47,700
+582% +$1.96M ﹤0.01% 5162
2024
Q1
$402K Buy
8,200
+5,600
+215% +$269K ﹤0.01% 8855
2023
Q4
$126K Sell
2,600
-2,000
-43% -$89.1K ﹤0.01% 10646
2023
Q3
$186K Buy
4,600
+700
+18% +$27.7K ﹤0.01% 10031
2023
Q2
$154K Buy
3,900
+1,400
+56% +$50.7K ﹤0.01% 10301
2023
Q1
$102K Sell
2,500
-1,300
-34% -$47.8K ﹤0.01% 11238
2022
Q4
$126K Buy
+3,800
New +$114K ﹤0.01% 10875
2022
Q2
Sell
-7,000
Closed -$363K 13052
2022
Q1
$363K Buy
7,000
+3,100
+79% +$159K ﹤0.01% 10152
2021
Q4
$263K Sell
3,900
-4,000
-51% -$288K ﹤0.01% 11223
2021
Q3
$575K Buy
+7,900
New +$581K ﹤0.01% 9534

Other funds holding DCBO

Citadel Advisors's DCBO Position: Q1 2026 in Review

Citadel Advisors sold out of Docebo (DCBO) in Q1 2026, closing a stake of 23,115 shares — an estimated $513K sold.

Citadel Advisors first reported a position in DCBO in Q1 2021 and held it in 19 quarters. The position peaked at $5.04M in Q2 2024. 67 funds tracked by Wall St. Rank hold DCBO as of Q1 2026.

  • Citadel Advisors reported no remaining Docebo position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 23,115 Docebo shares in Q1 2026, an estimated $513K.
  • Citadel Advisors first reported a position in Docebo in Q1 2021 and held it in 19 quarters.
  • Citadel Advisors's Docebo position peaked at $5.04M in Q2 2024.
  • 67 funds tracked by Wall St. Rank held Docebo as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.